Noninvasive prenatal testing: Need for informed enthusiasm

American Journal of Obstetrics and Gynecology

Volumn 211, Issue 6, 2014, Pages 577-580

  Han, Christina S ^a   Platt, Lawrence D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CHORIONIC GONADOTROPIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; RHESUS D ANTIBODY; ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; DNA;

ACCREDITATION; ADVERSE OUTCOME; AMNIOCENTESIS; ANEUPLOIDY; CELL SELECTION; CHORION VILLUS; CHORION VILLUS SAMPLING; CHROMOSOME DISORDER; CONGENITAL ADRENAL HYPERPLASIA; COST EFFECTIVENESS ANALYSIS; CYSTIC LYMPHANGIOMA; DNA SCREENING; FALSE POSITIVE RESULT; FETUS ECHOGRAPHY; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; GESTATIONAL AGE; GONADOTROPIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; MARKETING; MATERNAL SERUM; METABOLOMICS; MONOSOMY X; NON INVASIVE PROCEDURE; NUCHAL TRANSLUCENCY MEASUREMENT; POLYMERASE CHAIN REACTION; PRADER WILLI SYNDROME; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REASSURANCE; REVIEW; SENSITIVITY AND SPECIFICITY; TRISOMY; TRISOMY 13; TRISOMY 18; TRISOMY 21; BLOOD; CHROMOSOME DISORDERS; FEMALE; GENETICS; PRACTICE GUIDELINE; PREGNANCY; PROCEDURES; UNITED STATES;

ALPHA-FETOPROTEINS; AMNIOCENTESIS; CALIFORNIA; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHORIONIC VILLI SAMPLING; CHROMOSOME DISORDERS; DNA; FEMALE; GENETIC COUNSELING; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS;

EID: 84922512657     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.09.012     Document Type: Editorial

References (31)

1. O. Lapaire, W. Holzgreve, J.C. Oosterwijk, R. Brinkhaus, and D.W. Bianchi Georg Schmorl on trophoblasts in the maternal circulation Placenta 28 2007 1 5
2. Y.M. Lo, N. Corbetta, and P.F. Chamberlain Presence of fetal DNA in maternal plasma and serum Lancet 350 1997 485 487
3. Y.M. Lo Non-invasive prenatal testing using massively parallel sequencing of maternal plasma DNA: from molecular karyotyping to fetal whole-genome sequencing Reprod Biomed Online 27 2013 593 598
4. S. Larion, S.L. Warsof, L. Romary, M. Mlynarczyk, D. Peleg, and A.Z. Abuhamad Uptake of noninvasive prenatal testing at a large academic referral center Am J Obstet Gynecol 211 2014 651.e1 651.e7
5. L.D. Platt, M.B. Janicki, and T. Prosen Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States Am J Obstet Gynecol 211 2014 368.e1 368.e7
6. A.B. Sparks, C.A. Struble, E.T. Wang, K. Song, and A. Oliphant Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18 Am J Obstet Gynecol 206 2012 319.e1 319.e9
7. D.W. Bianchi, L.D. Platt, J.D. Goldberg, A.Z. Abuhamad, A.J. Sehnert, and R.P. Rava Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing Obstet Gynecol 119 2012 890 901
8. D.W. Bianchi, T. Prosen, and L.D. Platt Massively parallel sequencing of maternal plasma DNA in 113 cases of fetal nuchal cystic hygroma Obstet Gynecol 121 2013 1057 1062
9. P. Soothill, K. Finning, T. Latham, T. Wreford-Bush, J. Ford, and G. Daniels Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS BJOG 2014 Aug. 21 [Epub ahead of print] doi: 10.1111/1471-0528.13055.
10. American College of Obstetricians and Gynecologists Committee on Genetics Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion no. 545 Obstet Gynecol 120 2012 1532 1534
11. S. Chetty, M.J. Garabedian, and M.E. Norton Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening Prenat Diagn 33 2013 542 546
12. D.W. Bianchi, R.L. Parker, and J. Wentworth DNA sequencing versus standard prenatal aneuploidy screening N Engl J Med 370 2014 799 808
13. A. Buchanan, A. Sachs, T. Toler, and J. Tsipis NIPT: current utilization and implications for the future of prenatal genetic counseling Prenat Diagn 34 2014 850 857
14. R.P. Rava, A. Srinivasan, A.J. Sehnert, and D.W. Bianchi Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X Clini Chem 60 2014 243 250
15. G. Ashoor, A. Syngelaki, L.C. Poon, J.C. Rezende, and K.H. Nicolaides Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics Ultrasound Obstet Gynecol 41 2013 26 32
16. E. Pergament, H. Cuckle, and B. Zimmermann Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort Obstet Gynecol 124 2014 210 218
17. D. Oepkes, Y. Yaron, and P. Kozlowski Counseling for non-invasive prenatal testing (NIPT): what pregnant women may want to know Ultrasound Obstet Gynecol 44 2014 1 5
18. U.M. Reddy, A.Z. Abuhamad, D. Levine, and G.R. Saade Fetal imaging: Executive summary of a Joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop Am J Obstet Gynecol 210 2014 387 397
19. American College of Obstetricians and Gynecologists Fetal growth restriction. ACOG Practice bulletin no. 134 Obstet Gynecol 121 2013 1122 1133
20. U.D. Anderson, M.G. Olsson, K.H. Kristensen, B. Akerstrom, and S.R. Hansson Review: biochemical markers to predict preeclampsia Placenta 33 suppl 2012 S42 S47
21. I.A. Buhimschi, U.A. Nayeri, and G. Zhao Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia Sci Transl Med 6 2014 245ra92
22. A. Flick, D. Krakow, A. Martirosian, N. Silverman, and L.D. Platt Routine measurement of amniotic fluid alpha-fetoprotein and acetylcholinesterase: the need for a reevaluation Am J Obstet Gynecol 211 2014 139.e1 139.e6
23. Sequenom, Inc. Sequenom Laboratories launches the enhanced sequencing series for the MaterniT21 Plus Test. Available at: http://www.sequenom.com/press/sequenom-laboratories-launches-enhanced-sequencing-series-maternit21-plus-test. Accessed Oct. 23, 2014.
24. Progenity, Inc. Non-invasive prenatal testing. Available at: http://progenity.com/non-invasive-prenatal-testing. Accessed Oct. 23, 2014.
25. Hall M. Panoram non-invasive prenatal screening for microdeletion syndromes. Available at: http://www.panoramatest.com/sites/default/files/files/Panorama%20Microdeletions%20White%20Paper-2.pdf. Accessed Oct. 23, 2014.
26. M. Rabinowitz, M. Savage, B. Pettersen, S. Sigurjonsson, M. Hill, and B. Zimmermann Noninvasive cell-free DNA-based prenatal detection of microdeletions using single nucleotide polymorphism-targeted sequencing Obstet Gynecol 123 suppl 1 2014 167s
27. A.T. Bombard, D.H. Farkas, T.J. Monroe, and J.S. Saldivar Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution Obstet Gynecol 124 2014 379
28. N.L. Vora, and B.M. O'Brien Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution Obstet Gynecol 123 2014 1097 1099
29. S. Morris, S. Karlsen, N. Chung, M. Hill, and L.S. Chitty Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service PloS one 9 2014 e93559
30. M. Ohno, and A. Caughey The role of noninvasive prenatal testing as a diagnostic versus a screening tool: a cost-effectiveness analysis Prenat Diagn 33 2013 630 635
31. S.S. Garfield, and S.O. Armstrong Clinical and cost consequences of incorporating a novel non-invasive prenatal test into the diagnostic pathway for fetal trisomies J Managed Care Med 15 2012 34 41